{"date":"2026-03-23","count":36,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6709-2026-03-23-2127-6r49ey","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"21:27:51","subject":"公告本公司董事會決議虧損撥補案暨不發放股利","clause":"第31款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-03-23 21:27，「公告本公司董事會決議虧損撥補案暨不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2026-03-23-2059-1k6smg9","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"20:59:45","subject":"本公司董事會決議召開115年股東常會相關事項","clause":"第32款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-03-23 20:59，「本公司董事會決議召開115年股東常會相關事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2026-03-23-1941-drgvb6","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"19:41:34","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-03-23 19:41，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2026-03-23-1918-3qn6pb","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"19:18:12","subject":"公告本公司董事會決議114年度股利分派情形","clause":"第31款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2026-03-23 19:18，「公告本公司董事會決議114年度股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2026-03-23-1905-120388b","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"19:05:19","subject":"公告本公司董事會議決議召開股東常會相關事宜","clause":"第32款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2026-03-23 19:05，「公告本公司董事會議決議召開股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2026-03-23-1904-nq3yxb","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"19:04:02","subject":"公告本公司董事會決議不分派114年度員工酬勞及董事酬勞","clause":"第44款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2026-03-23 19:04，「公告本公司董事會決議不分派114年度員工酬勞及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2026-03-23-1903-1jp3ewj","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"19:03:13","subject":"公告本公司董事會通過114年度財務報表","clause":"第43款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2026-03-23 19:03，「公告本公司董事會通過114年度財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-03-23-1824-1suuuw8","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-03-23","time":"18:24:38","subject":"公告本公司3/26自辦國內法人說明會事宜","clause":"第30款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-03-23 18:24，「公告本公司3/26自辦國內法人說明會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-03-23-1814-3zq7ca","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-03-23","time":"18:14:56","subject":"公告本公司自辦國內法人說明會事宜","clause":"第30款","fact_date":"2026-03-25","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-03-23 18:14，「公告本公司自辦國內法人說明會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-03-23-1801-1kf1iya","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-03-23","time":"18:01:12","subject":"代重要子公司UOC Europe Holding SA公告召開股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-03-23 18:01，「代重要子公司UOC Europe Holding SA公告召開股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-03-23-1800-1th6q07","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-03-23","time":"18:00:41","subject":"代重要子公司United Orthopedic Corporation (France)公告本公司法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-03-23 18:00，「代重要子公司United Orthopedic Corporation (France)公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-03-23-1800-1feg8cd","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-03-23","time":"18:00:01","subject":"代重要子公司UOC Europe Holding SA公告本公司總經理異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-03-23 18:00，「代重要子公司UOC Europe Holding SA公告本公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2026-03-23-1743-bwopfv","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"17:43:39","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2026-03-23 17:43，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2026-03-23-1733-11b1948","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"17:33:42","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2026-03-23 17:33，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2026-03-23-1731-1v08jg1","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"17:31:33","subject":"公告本公司董事會決議辦理私募發行普通股","clause":"第9款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2026-03-23 17:31，「公告本公司董事會決議辦理私募發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2026-03-23-1731-16scejo","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"17:31:10","subject":"公告本公司董事會決議不繼續辦理民國114年股東常會通過之私募發行普通股案","clause":"第14款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2026-03-23 17:31，「公告本公司董事會決議不繼續辦理民國114年股東常會通過之私募發行普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2026-03-23-1730-r9cisp","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"17:30:51","subject":"公告本公司董事會決議通過以資本公積彌補虧損","clause":"第44款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2026-03-23 17:30，「公告本公司董事會決議通過以資本公積彌補虧損」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2026-03-23-1730-drgvb6","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"17:30:36","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2026-03-23 17:30，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2026-03-23-1730-5j9yh6","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"17:30:08","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2026-03-23 17:30，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-03-23-1710-3ja4ox","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-03-23","time":"17:10:14","subject":"公告本公司國內第一次有擔保轉換公司債收足債款","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-03-23 17:10，「公告本公司國內第一次有擔保轉換公司債收足債款」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2026-03-23-1701-gnjdav","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"17:01:42","subject":"公告本公司因會計師事務所內部輪調政策更換簽證會計師","clause":"第7款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2026-03-23 17:01，「公告本公司因會計師事務所內部輪調政策更換簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-23-1656-xrt51t","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"16:56:30","subject":"公告本公司法人董事辭任暨董事變動達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-23 16:56，「公告本公司法人董事辭任暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2026-03-23-1653-1lw07w8","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"16:53:48","subject":"公告本公司董事會通過114年度第4季個別財務報告","clause":"第43款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2026-03-23 16:53，「公告本公司董事會通過114年度第4季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2026-03-23-1649-bwopfv","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"16:49:56","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2026-03-23 16:49，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2026-03-23-1634-ftq9yq","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"16:34:33","subject":"公告本公司訂定115年現金增資認股基準日及相關事宜","clause":"第9款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-03-23 16:34，「公告本公司訂定115年現金增資認股基準日及相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-03-23-1630-1ds8yo","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-03-23","time":"16:30:04","subject":"公告本公司更正114年度個別財務報告之本期發生之員工福利、折舊、折耗及攤銷費用功能別彙總附註","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-03-23 16:30，「公告本公司更正114年度個別財務報告之本期發生之員工福利、折舊、折耗及攤銷費用功能別彙總附註」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2026-03-23-1624-1v75o42","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"16:24:17","subject":"公告本公司限制員工權利新股收回註銷減資變更登記完成","clause":"第35款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2026-03-23 16:24，「公告本公司限制員工權利新股收回註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2026-03-23-1623-m6v03s","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"16:23:11","subject":"公告本公司董事會決議召開115年股東會事宜","clause":"第32款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2026-03-23 16:23，「公告本公司董事會決議召開115年股東會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-03-23-1601-1e0tlii","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-23","time":"16:01:22","subject":"公告本公司功能性委員會委員異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-03-23 16:01，「公告本公司功能性委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-03-23-1548-152642x","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-23","time":"15:48:04","subject":"代子公司依公開發行公司資金貸與及背書保證處理準則第25條第1項第4款公告","clause":"第22款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-03-23 15:48，「代子公司依公開發行公司資金貸與及背書保證處理準則第25條第1項第4款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-03-23-1547-1j4f2tm","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-23","time":"15:47:13","subject":"依公開發行公司資金貸與及背書保證處理準則第25條第1項第4款公告","clause":"第22款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-03-23 15:47，「依公開發行公司資金貸與及背書保證處理準則第25條第1項第4款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-03-23-1510-vybwpi","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-03-23","time":"15:10:49","subject":"本公司受邀參加德信綜合證券所舉辦之線上法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-03-23 15:10，「本公司受邀參加德信綜合證券所舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4111-2026-03-23-1451-100esni","company_id":"4111","company":"濟生","market":"上櫃","industry":"生技醫療","date":"2026-03-23","time":"14:51:15","subject":"公告本公司研發主管異動","clause":"第8款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：濟生（4111），2026-03-23 14:51，「公告本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-03-23-1432-1ap8fql","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-03-23","time":"14:32:46","subject":"公告本公司註銷收回之限制員工權利新股辦理減資變更登記完成","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-03-23 14:32，「公告本公司註銷收回之限制員工權利新股辦理減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-03-23-1431-1nsksc0","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-03-23","time":"14:31:21","subject":"本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-03-23 14:31，「本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2026-03-23-0806-opxbsb","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2026-03-23","time":"08:06:21","subject":"本公司與日本化藥簽署抗體藥GNX201-ADC共同開發計畫","clause":"第10款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2026-03-23 08:06，「本公司與日本化藥簽署抗體藥GNX201-ADC共同開發計畫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}